Pashtoon Kasi/LinkedIn
Aug 12, 2025, 16:39
Pashtoon Kasi: Hot Off the Press – KRAS Vaccine for Patients with RAS+ Cancers
Pashtoon Kasi, Medical Director at City of Hope, shared on LinkedIn:
“Hot off the press!
KRAS Vaccine for patients with RAS+ cancers.
Benefit → durable.
More to come with the randomized study!
Opens to doors to off the shelf vaccine for so many patients with KRAS/NRAS mutations.”
Title: Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final results
Journal: Nature Medicine
Authors: Zev A. Wainberg, Colin D. Weekes, Muhammad Furqan, Pashtoon M. Kasi, Craig E. Devoe, Alexis D. Leal, Vincent Chung, James R. Perry, Thian Kheoh, Lisa K. McNeil, Esther Welkowsky, Peter C. DeMuth, Christopher M. Haqq, Shubham Pant, Eileen M. O’Reilly
More posts featuring Pashtoon Kasi on OncoDaily.
Alexis D. Leal
AMPLIFY-201
cancer
Christopher M. Haqq
City of Hope
Colin D. Weekes
colorectal cancer
Craig E Devoe
Eileen M. O'Reilly
Esther Welkowsky
James R. Perry
KRAS Vaccine
KRAS/NRAS mutations
Lisa K. McNeil
mKRAS-specific amphiphile vaccine
Muhammad Furqan
OncoDaily
Oncology
Pancreatic Cancer
Pashtoon Kasi
Pashtoon M. Kasi
Peter C. DeMuth
RAS+ Cancers
Shubham Pant
Thian Kheoh
Vincent Chung
Zev A. Wainberg
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 2, 2025, 20:50
Sep 2, 2025, 18:53
Sep 2, 2025, 16:54
Sep 2, 2025, 16:41